Request Deal Involvement
Triwise Capital led a $131m in Series B round in Immune-Onc Therapeutics.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
pr advisors
The Grace Communication Group
or
Principals
bidder
WUXI BIOLOGICS
bidder
TRIWISE CAPITAL
target
IMMUNE-ONC THERAPEUTICS
bidder
PROXIMA VENTURES
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite